ROIV vs TECH · rev $29.1M vs P/E 65, rev $1.22B
Roivant Sciences Ltd (ROIV) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ROIV revenue for 2025-03-31 was $29.1M. Net income was -$356.7M. Revenue was down 11.2% from 2024-03-31 to 2025-03-31. ROIV currently screens at market cap $7.47B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ROIV currently screens at market cap $7.47B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ROIV and TECH stock pages for the full models.
Not investment advice.